Sheena Jonathan has filed a Form 144 to sell 9,450 shares of Natera, Inc. on October 21, 2026. This filing is significant as it indicates Jonathan's intention to liquidate part of her holdings in the company, which operates in the medical laboratory services sector.
Natera, Inc., identified by CIK 0001604821, is incorporated in Delaware and is publicly traded on the NASDAQ under the SEC file number 001-37478. The company's fiscal year ends on December 31. Natera specializes in genetic testing and other medical laboratory services.
The filing reveals that Jonathan's shares were acquired through various stock options on November 2, 2016. The aggregate market value of the shares being sold is approximately $3,879,737. The filing also notes that Jonathan has sold additional shares in the past three months, reflecting ongoing trading activity.
This move may affect Natera's investors and market analysts, as insider selling can influence perceptions of a company's future performance. Additionally, it may prompt competitors in the medical laboratory services sector to reassess their strategies in light of these developments.
The filing does not specify what actions will follow this sale.
Details of the Sale
Sheena Jonathan's Form 144 indicates that the shares being sold are common stock, and they were acquired on November 2, 2016, through various stock options. This type of acquisition typically involves options granted as part of an employee compensation package, which aligns with Jonathan's role as a director at Natera.
Recent Trading Activity
In addition to the upcoming sale of 9,450 shares, the filing details that Jonathan has been active in the market over the past three months, selling a total of 28,288 shares. This includes several transactions, with the largest being 18,064 shares sold on September 23, 2026, which generated gross proceeds of approximately $7,008,972. Other notable sales include 6,000 shares on September 15, 2026, and 9,150 shares on August 7, 2026, indicating a significant level of trading activity.
Broker Information
The shares are being sold through Charles Schwab & Co., Inc., a well-known brokerage firm. This choice of broker may reflect Jonathan's strategy in managing her investments and executing trades efficiently.
Overall, the filing illustrates a strategic move by Jonathan, who has been actively managing her holdings in Natera, reflecting both market conditions and personal financial planning.